IMVT R&D Expenses
Immunovant Inc · R&D Expenses
IMVT R&D Expenses
Latest reported$498.09Mperiod ending
IMVT R&D Expenses ($135.26M → $498.09M)
Annual R&D Expenses
High-resolution chart · PNG
IMVT r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 456,660,000 | |
| 360,917,000 | |
| 212,928,000 | |
| 160,257,000 | |
| 101,808,000 | |
| 68,604,000 | |
| 47,927,000 | |
| 25,733,000 | |
| 135,263,000 |